New Leaf Venture Partners LLC purchased $8M worth of shares in Aptinyx, Inc. in June 2018
Jul 08, 2018
Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.
In The News
Aug 12, 2019 - SEC
Aug 12, 2019 - GlobeNewswire
Aug 05, 2019 - GlobeNewswire
New Leaf Ventures Partners focuses exclusively in healthcare companies located in the US with strong management teams and revenues exceeding $100 million. They targets companies operating in the fields of biopharmaceutical, information convergence (HCIT), medical device and life science tools.The firm provides financing for early and later stage capital requirements and invests in both public & private companies.
In The News
Aug 14, 2019 - peHUB
New Leaf Venture Partners LLC purchased $6M worth of shares in Harpoon Therapeutics, Inc. in February 2019
Mar 08, 2019 - RelSci